Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Frequently asked questions
What is the Tema Oncology ETF (CANC) expense ratio?
The Tema Oncology ETF funds expense ratio is 0.75%.
What is Tema Oncology ETF (CANC) current stock price?
As of the latest data, Tema Oncology ETF stock price is $43.82, with a previous close of $43.25. Tema Oncology ETF gained $0.57 in the last trading session, representing a 1.32% increase.
Does Tema Oncology ETF (CANC) pay dividends?
Yes. Tema Oncology ETF pays annual dividends with an annualized yield of 0.05% and an estimated annual payout of $0.02 per share.